<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04253899</url>
  </required_header>
  <id_info>
    <org_study_id>1504002-3</org_study_id>
    <nct_id>NCT04253899</nct_id>
  </id_info>
  <brief_title>The Management of Perforated Acute Appendicitis in Adult and Pediatric Populations</brief_title>
  <official_title>The Management of Perforated Acute Appendicitis: A Randomized Control Trial in the Adult and Pediatric Populations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marshall University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marshall University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients admitted at Marshall Health - Cabell Huntington Hospital with the diagnosis of acute
      perforated appendicitis or appendicular abscess larger than 3cm will be admitted and treated
      with percutaneous drainage and the IV antibiotics for 3 days. If the patient becomes afebrile
      and has a normal WBC, the patient will stay in the hospital for a single day with oral
      antibiotics and then will be discharged to continue oral antibiotics for seven more days. If
      the patient is febrile or has elevated WBC either after the 3 days of IV antibiotics or the
      single day of oral antibiotics, the patient will complete a course of IV antibiotics for a
      total of seven days. If still febrile, the patient will undergo further assessment.

      A follow up will be conducted ~10 days after discharge from the hospital to determine if the
      patient is still symptomatic or asymptomatic. Asymptomatic patients will be followed up every
      month for 3 months, while symptomatic patients will be treated as needed. After 12 weeks,
      subjects will be randomized to interval appendectomy vs observation. Follow-ups will occur
      every 3 months for 12 months, when the study will be concluded.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine rate and severity of complications after interval appendectomy</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the incidence and rate of appendectomies (in the observation arm) during the first year of diagnosis</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the rate of complete response after percutaneous drainage and antibiotic therapy</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean surgical value (quality/cost) for each group</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Perforated Appendicitis</condition>
  <arm_group>
    <arm_group_label>Standard pediatric group:</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients ≤17 yo with acute perforated appendicitis and interval appendectomy (n=25)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental pediatric group:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients ≤17 yo with acute perforated appendicitis abscess and observation (n=25)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard adult group:</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients ≥18 yo with acute perforated appendicitis and interval appendectomy (n=25)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental adult group:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients ≥18 yo with acute perforated appendicitis and observation (n=25)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Appendectomy</intervention_name>
    <description>Interval Appendectomy</description>
    <arm_group_label>Standard adult group:</arm_group_label>
    <arm_group_label>Standard pediatric group:</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>observation and follow up</description>
    <arm_group_label>Experimental adult group:</arm_group_label>
    <arm_group_label>Experimental pediatric group:</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women of all ages.

          -  Clinical and radiological diagnosis by contrast CT scan of acute perforated
             appendicitis.

          -  Formal consent for the present study must be signed by the patient or his/her parents

          -  Patients with initial presentation of a phlegmon (abscess in evolution)

        Exclusion Criteria:

          -  Patients with non-perforated appendicitis

          -  Presentation with initially non-perforated appendicitis but found perforation at
             surgery

          -  Patient with septic shock

          -  Patients who had previous appendectomy

          -  Current treatment of malignancy

          -  Immunocompromised patients

          -  Positive pregnancy test

          -  No consent for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Sanabria, MD MSc FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marshall University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Sanabria, MD MSc FACS</last_name>
    <phone>216 647 8399</phone>
    <email>sanabriaj@marshall.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Abdelmasseh, MD</last_name>
    <email>abdelmasseh@marshall.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Marshall University School of Medicine</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Sanabria, MD MSc FACS</last_name>
      <phone>216-647-8399</phone>
      <email>sanabriaj@marshall.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 29, 2020</study_first_submitted>
  <study_first_submitted_qc>January 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>January 31, 2020</last_update_submitted>
  <last_update_submitted_qc>January 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Marshall University</investigator_affiliation>
    <investigator_full_name>Juan Sanabria</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>Perforated appendicitis</keyword>
  <keyword>Pediatric appendicitis</keyword>
  <keyword>Appendectomy</keyword>
  <keyword>Appendiceal abscess</keyword>
  <keyword>Antibiotic Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

